Skip to main content
Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
46.74
+0.58 (1.26%)
At close: Mar 9, 2026, 4:00 PM EDT
46.28
-0.46 (-0.98%)
After-hours: Mar 9, 2026, 5:20 PM EDT

KNSA Revenue

In the year 2025, Kiniksa Pharmaceuticals International, had annual revenue of $677.56M with 60.09% growth. Kiniksa Pharmaceuticals International, had revenue of $202.13M in the quarter ending December 31, 2025, with 64.95% growth.

Revenue (ttm)
$677.56M
Revenue Growth
+60.09%
P/S Ratio
5.20
Revenue / Employee
$1,851,268
Employees
366
Market Cap
3.58B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025677.56M254.33M60.09%
Dec 31, 2024423.24M152.98M56.60%
Dec 31, 2023270.26M50.08M22.74%
Dec 31, 2022220.18M181.64M471.24%
Dec 31, 202138.54M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 10.27B
Amneal Pharmaceuticals 3.02B
Hims & Hers Health 2.35B
Lantheus Holdings 1.54B
Alkermes 1.48B
Phibro Animal Health 1.46B
Prestige Consumer Healthcare 1.10B
BioCryst Pharmaceuticals 874.84M
Revenue Rankings

KNSA News

More News